MiR-206, miR-30a-5p, and miR-613, all of which are elevated in the CSF of AD patients, have been found to target and downregulate BDNF (Lee et al., 2012; Croce et al., 2013; Li et al., 2016). This evidence concerns the gene BDNF and Alzheimer disease.